We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Safety and tolerability of regadenoson in 514 SPECT MPI patients with and without coronary artery disease and submaximal exercise heart rate response.
- Authors
AlJaroudi, Wael A; Alraies, M C; Cerquiera, Manuel D; Jaber, Wael A
- Abstract
The safety of regadenoson (Reg) during low-level exercise testing has been established. However, its administration at peak exercise for patients who do not reach target heart rate (THR) on standard exercise treadmill stress testing (ETT) needs to be established, particularly among patients with known coronary artery disease (CAD) METHODS: From our stress myocardial perfusion imaging (MPI) database, we identified all patients between 2009 and 2012 who underwent standard ETT and received Reg at peak exercise for failure to reach THR. Hemodynamics, side effects, and adverse events were entered prospectively into the database at the time of testing and were subsequently retrieved for analysis.
- Publication
European journal of nuclear medicine and molecular imaging, 2013, Vol 40, Issue 3, p341
- ISSN
1619-7089
- Publication type
Journal Article
- DOI
10.1007/s00259-012-2296-4